Regeneron Pharmaceuticals Inc (REGN)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 3,953,600 3,991,100 4,299,000 4,182,700 4,338,400 5,370,300 5,686,800 7,933,600 8,075,300 6,995,500 6,205,400 4,003,800 3,513,200 3,156,000 2,983,500 2,279,300 2,115,800 2,144,200 2,069,300 2,427,600
Total assets US$ in thousands 33,080,200 32,163,300 30,657,500 30,059,900 29,214,500 27,677,800 27,205,800 26,348,700 25,434,800 23,671,500 21,485,900 17,772,200 17,163,300 16,084,000 14,428,700 15,757,500 14,805,200 13,939,300 13,173,600 12,854,800
ROA 11.95% 12.41% 14.02% 13.91% 14.85% 19.40% 20.90% 30.11% 31.75% 29.55% 28.88% 22.53% 20.47% 19.62% 20.68% 14.46% 14.29% 15.38% 15.71% 18.88%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $3,953,600K ÷ $33,080,200K
= 11.95%

Regeneron Pharmaceuticals, Inc.'s return on assets (ROA) has shown a declining trend over the past eight quarters. The ROA decreased from 30.11% in Q1 2022 to 11.95% in Q4 2023. This significant decline indicates a decrease in the company's ability to generate earnings relative to its total assets.

The ROA peaked at 30.11% in Q1 2022, suggesting that the company was efficiently utilizing its assets to generate profits. However, the consistent decline in ROA since then may raise concerns about the company's asset management efficiency.

The average ROA over the past eight quarters is approximately 17.89%. A declining trend in ROA could indicate challenges in maintaining profitability or inefficiencies in asset utilization. Further analysis of the company's financial health, operational efficiency, and strategic decisions would be necessary to understand the underlying factors causing the decline in ROA.


Peer comparison

Dec 31, 2023


See also:

Regeneron Pharmaceuticals Inc Return on Assets (ROA) (Quarterly Data)